Publisher
Springer Science and Business Media LLC
Subject
Cancer Research,Oncology,General Medicine
Reference28 articles.
1. Beiske K et al (2009) Consensus criteria for sensitive detection of minimal neuroblastoma cells in bone marrow, blood and stem cell preparations by immunocytology and QRT-PCR: recommendations by the International Neuroblastoma Risk Group Task Force. Br J Cancer 100:1627–1637.
https://doi.org/10.1038/sj.bjc.6605029
2. Berthold F, Spix C, Kaatsch P, Lampert F (2017) Incidence, survival, and treatment of localized and metastatic neuroblastoma in Germany 1979–2015. Paediatr Drugs 19:577–593.
https://doi.org/10.1007/s40272-017-0251-3
3. Bomken SN, Redfern K, Wood KM, Reid MM, Tweddle DA (2006) Limitations in the ability of NB84 to detect metastatic neuroblastoma cells in bone marrow. J Clin Pathol 59:927–929.
https://doi.org/10.1136/jcp.2005.035444
4. Bozzi F, Gambirasio F, Luksch R, Collini P, Brando B, Fossati-Bellani F (2006) Detecting CD56+/NB84+/CD45- immunophenotype in the bone marrow of patients with metastatic neuroblastoma using flow cytometry. Anticancer Res 26:3281–3287
5. Bozzi F et al (2008) Flow cytometric phenotype of rhabdomyosarcoma bone marrow metastatic cells and its implication in differential diagnosis with neuroblastoma. Anticancer Res 28:1565–1569
Cited by
15 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献